| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 264-275, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
AB Kulkarni, JM Ward, L Yaswen, CL Mackall, SR Bauer, CG Huh, RE Gress and S Karlsson
Molecular and Medical Genetics Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
Approximately 40% of transforming growth factor-beta 1 null (knockout) mice generated in our laboratory develop normally to term, but 60% die in utero. The animals appear normal during the first 2 weeks of life but develop a rapid wasting syndrome and die by 3 to 4 weeks of age. All of the knockout mice have a multifocal inflammatory disease in many tissues. The heart and lungs are most severely affected. Increased adhesion of leukocytes to the endothelium of pulmonary veins is the initial lesion seen at day 8 postnatally and is soon followed by perivascular cuffing as well as inflammatory infiltrates in lung parenchyma. The lesions in the heart begin as endocarditis and then progress to myocarditis and pericarditis. Within the lung, chronic inflammatory infiltrates consist of T and B lymphocytes, including plasma cells, whereas macrophages are the primary inflammatory cell type in the heart. Increased expression of major histocompatibility complex class I and II proteins is seen in pulmonary vascular endothelium as early as day 8. An immunoblastic response in mediastinal and mandibular lymph nodes and spleen is also seen. In the absence of any pathogens, this massive inflammatory disease, together with overexpression of major histocompatibility complex class I and II proteins and overproduction of immunoglobulins by lymphocytes, offers circumstantial evidence for an autoimmune etiology.
This article has been cited by other articles:
 |
|
 |
|
  J. Letterio, E. Rudikoff, N. Voong, and S. R. Bauer Transforming Growth Factor-{beta}1 Sensitivity Is Altered in Abl-Myc- and Raf-Myc-Induced Mouse Pre-B-Cell Tumors Stem Cells, December 1, 2006; 24(12): 2611 - 2617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Leveen, M. Carlsen, A. Makowska, S. Oddsson, J. Larsson, M.-J. Goumans, C. M. Cilio, and S. Karlsson TGF-{beta} type II receptor-deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivo Blood, December 15, 2005; 106(13): 4234 - 4240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Ruiz, A. Shkoda, S. C. Kim, R. B. Sartor, and D. Haller IL-10 Gene-Deficient Mice Lack TGF-{beta}/Smad Signaling and Fail to Inhibit Proinflammatory Gene Expression in Intestinal Epithelial Cells after the Colonization with Colitogenic Enterococcus faecalis J. Immunol., March 1, 2005; 174(5): 2990 - 2999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Afanasyeva, D. Georgakopoulos, D. Fairweather, P. Caturegli, D. A. Kass, and N. R. Rose Novel Model of Constrictive Pericarditis Associated With Autoimmune Heart Disease in Interferon-{gamma}-Knockout Mice Circulation, November 2, 2004; 110(18): 2910 - 2917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rosendahl, M. Speletas, K. Leandersson, F. Ivars, and P. Sideras Transforming growth factor-{beta}- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis Int. Immunol., December 1, 2003; 15(12): 1401 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Larsson, U. Blank, H. Helgadottir, J. M. Bjornsson, M. Ehinger, M.-J. Goumans, X. Fan, P. Leveen, and S. Karlsson TGF-{beta} signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro Blood, November 1, 2003; 102(9): 3129 - 3135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Haller, L. Holt, S. C. Kim, R. F. Schwabe, R. B. Sartor, and C. Jobin Transforming Growth Factor-{beta}1 Inhibits Non-pathogenic Gramnegative Bacteria-induced NF-{kappa}B Recruitment to the Interleukin-6 Gene Promoter in Intestinal Epithelial Cells through Modulation of Histone Acetylation J. Biol. Chem., June 20, 2003; 278(26): 23851 - 23860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schramm, M. Protschka, H. H. Kohler, J. Podlech, M. J. Reddehase, P. Schirmacher, P. R. Galle, A. W. Lohse, and M. Blessing Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice Am J Physiol Gastrointest Liver Physiol, March 1, 2003; 284(3): G525 - G535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Burt, A. Traynor, Y. Oyama, and R. Craig High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease Blood, March 1, 2003; 101(5): 2064 - 2066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Leveen, J. Larsson, M. Ehinger, C. M. Cilio, M. Sundler, L. J. Sjostrand, R. Holmdahl, and S. Karlsson Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable Blood, June 28, 2002; 100(2): 560 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guo, P. A. Mathieu, B. Linebaugh, B. F. Sloane, and J. J. Reiners Jr. Phorbol Ester Activation of a Proteolytic Cascade Capable of Activating Latent Transforming Growth Factor-beta . A PROCESS INITIATED BY THE EXOCYTOSIS OF CATHEPSIN B J. Biol. Chem., April 19, 2002; 277(17): 14829 - 14837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Grande, G. M. Warner, H. J. Walker, A. N. K. Yusufi, J. Cheng, C. E. Gray, J. B. Kopp, and K. A. Nath TGF-{beta}1 Is an Autocrine Mediator of Renal Tubular Epithelial Cell Growth and Collagen IV Production Experimental Biology and Medicine, March 1, 2002; 227(3): 171 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Gorham, J. T. Lin, J. L. Sung, L. A. Rudner, and M. A. French Genetic Regulation of Autoimmune Disease: BALB/c Background TGF-{{beta}}1-Deficient Mice Develop Necroinflammatory IFN-{{gamma}}-Dependent Hepatitis J. Immunol., May 15, 2001; 166(10): 6413 - 6422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Anti-Inflammatory Mechanisms in the Vascular Wall Circ. Res., May 11, 2001; 88(9): 877 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Grainger, D. Mosedale, J. Metcalfe, and E. Bottinger Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions J. Cell Sci., January 7, 2000; 113(13): 2355 - 2361. [Abstract] [PDF]
|
|
|
|
|
|
S. Kobayashi, K. Yoshida, J. M. Ward, J. J. Letterio, G. Longenecker, L. Yaswen, B. Mittleman, E. Mozes, A. B. Roberts, S. Karlsson, et al. {beta}2-Microglobulin-Deficient Background Ameliorates Lethal Phenotype of the TGF-{beta}1 Null Mouse J. Immunol., October 1, 1999; 163(7): 4013 - 4019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W. v. Ginkel, S. M. Wahl, J. F. Kearney, M.-N. Kweon, K. Fujihashi, P. D. Burrows, H. Kiyono, and J. R. McGhee Partial IgA-Deficiency with Increased Th2-Type Cytokines in TGF-{beta}1 Knockout Mice J. Immunol., August 15, 1999; 163(4): 1951 - 1957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G V McDonnell, C W Kirk, S A Hawkins, and C A Graham Lack of association of transforming growth factor (TGF)-b1 and b2 gene polymorphisms with multiple sclerosis (MS) in Northern Ireland Multiple Sclerosis, April 1, 1999; 5(2): 105 - 109. [Abstract] [PDF]
|
|
|
|
 |
|
 D. M. Brass, G. W. Hoyle, H. G. Poovey, J.-Y. Liu, and A. R. Brody Reduced Tumor Necrosis Factor-{alpha} and Transforming Growth Factor-ß1 Expression in the Lungs of Inbred Mice that Fail to Develop Fibroproliferative Lesions Consequent to Asbestos Exposure Am. J. Pathol., March 1, 1999; 154(3): 853 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Leach, N. J. Davidson, M. M. Fort, F. Powrie, and D. M. Rennick The Role of IL-10 in Inflammatory Bowel Disease: "Of Mice and Men" Toxicol Pathol, January 1, 1999; 27(1): 123 - 133. [Abstract] [PDF]
|
|
|
|
 |
|
 M. E. Harris-White, T. Chu, Z. Balverde, J. J. Sigel, K. C. Flanders, and S. A. Frautschy Effects of Transforming Growth Factor-beta (Isoforms 1-3) on Amyloid-beta Deposition, Inflammation, and Cell Targeting in Organotypic Hippocampal Slice Cultures J. Neurosci., December 15, 1998; 18(24): 10366 - 10374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Melrose, N. Tsurushita, G. Liu, and E. L. Berg IFN-{gamma} Inhibits Activation-Induced Expression of E- and P-Selectin on Endothelial Cells J. Immunol., September 1, 1998; 161(5): 2457 - 2464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. O'Brien, K. L. Bennett, M. R. Garvin, T. W. Zderic, T. Hinohara, J. B. Simpson, T. Kimura, M. Nobuyoshi, H. Mizgala, A. Purchio, et al. ßig-h3, a Transforming Growth Factor–ß–Inducible Gene, Is Overexpressed in Atherosclerotic and Restenotic Human Vascular Lesions Arterioscler. Thromb. Vasc. Biol., April 1, 1996; 16(4): 576 - 584. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Mallat, A. Gojova, C. Marchiol-Fournigault, B. Esposito, C. Kamate, R. Merval, D. Fradelizi, and A. Tedgui Inhibition of Transforming Growth Factor-{beta} Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice Circ. Res., November 9, 2001; 89(10): 930 - 934. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
